Journal of Vascular and Interventional Radiology
Volume 20, Issue 7 , Pages 879-887 , July 2009

MR Imaging–guided Percutaneous Sclerotherapy of Peripheral Venous Malformations with a Clinical 1.5-T Unit: A Pilot Study

  • Gustav Andreisek, MD

      Affiliations

    • Institute for Diagnostic Radiology, University Hospital Zuerich, Raemistrasse 100, CH- 8091 Zürich, Switzerland
    • Corresponding Author InformationAddress correspondence to G.A.
    • ,
  • Daniel Nanz, PhD

      Affiliations

    • Department of Medical Radiology, University Hospital Zuerich, Raemistrasse 100, CH- 8091 Zürich, Switzerland
    • ,
  • Dominik Weishaupt, MD

      Affiliations

    • Division of Radiology, Triemli Hospital, Zürich, Switzerland
    • ,
  • Thomas Pfammatter, MD

      Affiliations

    • Institute for Diagnostic Radiology, University Hospital Zuerich, Raemistrasse 100, CH- 8091 Zürich, Switzerland

Received 29 November 2007 ,Revised 22 February 2009 ,Accepted 9 March 2009.

References 

  1. Burrows PE, Mason KP. Percutaneous treatment of low flow vascular malformations. J Vasc Interv Radiol. 2004;15:431–445
  2. Scherer K, Waner M. Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci. 2007;22:119–126
  3. Yakes WF, Haas DK, Parker SH, et al. Symptomatic vascular malformations: ethanol embolotherapy. Radiology. 1989;170:1059–1066
  4. Yakes WF, Rossi P, Odink H. How I do it: arteriovenous malformation management. Cardiovasc Intervent Radiol. 1996;19:65–71
  5. Rimon U, Garniek A, Galili Y, et al. Ethanol sclerotherapy of peripheral venous malformations. Eur J Radiol. 2004;52:283–287
  6. Shireman PK, McCarthy WJ, Yao JS, Vogelzang RL. Treatment of venous malformations by direct injection with ethanol. J Vasc Surg. 1997;26:838–844
  7. Mahesh B, Thulkar S, Joseph G, Khazanchi RK, Srivastava A. Colour duplex ultrasound-guided sclerotherapy: a new approach to the management of patients with peripheral vascular malformations. Clin Imaging. 2003;27:171–179
  8. Yamaki T, Nozaki M, Sasaki K. Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg. 2000;26:323–328
  9. Deveikis JP. Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck. Arch Facial Plast Surg. 2005;7:322–325
  10. Do YS, Yakes WF, Shin SW, et al. Ethanol embolization of arteriovenous malformations: interim results. Radiology. 2005;235:674–682
  11. Yakes WF, Luethke JM, Parker SH, et al. Ethanol embolization of vascular malformations. Radiographics. 1990;10:787–796
  12. Boll DT, Merkle EM, Lewin JS. Low-flow vascular malformations: MR-guided percutaneous sclerotherapy in qualitative and quantitative assessment of therapy and outcome. Radiology. 2004;233:376–384
  13. Boll DT, Merkle EM, Lewin JS. MR-guided percutaneous sclerotherapy of low-flow vascular malformations in the head and neck. Magn Reson Imaging Clin N Am. 2005;13:595–600
  14. Lewin JS, Merkle EM, Duerk JL, Tarr RW. Low-flow vascular malformations in the head and neck: safety and feasibility of MR imaging-guided percutaneous sclerotherapy—preliminary experience with 14 procedures in three patients. Radiology. 1999;211:566–570
  15. Herborn CU, Goyen M, Lauenstein TC, et al. Comprehensive time-resolved MRI of peripheral vascular malformations. AJR Am J Roentgenol. 2003;181:729–735
  16. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology. 2002;225:43–52
  17. van Rijswijk CS, van der Linden E, van der Woude HJ, van Baalen JM, Bloem JL. Value of dynamic contrast-enhanced MR imaging in diagnosing and classifying peripheral vascular malformations. AJR Am J Roentgenol. 2002;178:1181–1187
  18. Nanz D, Andreisek G, Frohlich JM, et al. Contrast material–enhanced visualization of the ablation medium for magnetic resonance–monitored ethanol injection therapy: imaging and safety aspects. J Vasc Interv Radiol. 2006;17:95–102
  19. Genant JW, Vandevenne JE, Bergman AG, et al. Interventional musculoskeletal procedures performed by using MR imaging guidance with a vertically open MR unit: assessment of techniques and applicability. Radiology. 2002;223:127–136
  20. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199–S202
  21. Donnelly LF, Bisset GS, Adams DM. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect. Pediatr Radiol. 2000;30:415–419
  22. Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE. Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J Vasc Interv Radiol. 2006;17:1639–1648
  23. Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223:639–644
  24. Binkert CA, Zanetti M, Gerber C, Hodler J. MR arthrography of the glenohumeral joint: two concentrations of gadoteridol versus Ringer solution as the intraarticular contrast material. Radiology. 2001;220:219–224
  25. Hammer FD, Boon LM, Mathurin P, Vanwijck RR. Ethanol sclerotherapy of venous malformations: evaluation of systemic ethanol contamination. J Vasc Interv Radiol. 2001;12:595–600
  26. Lee BB, Do YS, Yakes W, et al. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg. 2004;39:590–600
  27. Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol. 1983;141:483–488
  28. Choi YH, Han MH KOK, Cha SH, Chang KH. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate. J Vasc Interv Radiol. 2002;13:475–482
  29. Lee JJ, Do YS, Kim JA. Serum ethanol levels after alcohol sclerotherapy of arteriovenous malformations. J Korean Med Sci. 2004;19:51–54
  30. Mimura H, Kanazawa S, Yasui K, et al. Percutaneous sclerotherapy for venous malformations using polidocanol under fluoroscopy. Acta Med Okayama. 2003;57:227–234
  31. Tan KT, Kirby J, Rajan DK, et al. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol. 2007;18:343–351
  32. Friedman MA, Wood BJ. Precipitation of gadolinium and ethanol during nerve block. J Vasc Interv Radiol. 2003;14:394
  33. Wysoki MG, White RI. Crystallization when mixing contrast materials with ethanol for embolization of venous malformations. J Vasc Interv Radiol. 2001;12:264
  34. Hayashi N, Masumoto T, Okubo T, et al. Hemangiomas in the face and extremities: MR-guided sclerotherapy—optimization with monitoring of signal intensity changes in vivo. Radiology. 2003;226:567–572

 None of the authors have identified a conflict of interest.

PII: S1051-0443(09)00332-7

doi: 10.1016/j.jvir.2009.03.034

Journal of Vascular and Interventional Radiology
Volume 20, Issue 7 , Pages 879-887 , July 2009

Article Tools

* Image Usage & Resolution